三诺生物
(300298)
| 流通市值：73.74亿 | | | 总市值：91.66亿 |
| 流通股本：4.48亿 | | | 总股本：5.57亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 2,537,036,279.21 | 1,239,411,700.81 | 4,659,335,913.5 | 3,453,271,477.26 |
| 营业总成本 | 2,281,588,826.25 | 1,113,224,377.19 | 4,459,321,309.32 | 3,338,133,962.97 |
| 其他经营收益 | | | | |
| 营业利润 | 265,122,707.74 | 117,627,614.12 | 64,007,025.33 | 176,616,106.29 |
| 利润总额 | 268,205,078.54 | 120,396,466.92 | 74,054,037.07 | 190,767,223.84 |
| 净利润 | 226,680,605.13 | 102,991,394.24 | 22,076,674.05 | 152,743,949.16 |
| 每股收益 | | | | |
| 其他综合收益 | -52,000,501.43 | -27,511,297.91 | -34,957,876.86 | -4,351,539.6 |
| 综合收益总额 | 174,680,103.7 | 75,480,096.33 | -12,881,202.81 | 148,392,409.56 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,512,168,111.2 | 2,318,528,724.85 | 2,464,758,623.41 | 2,582,645,054.19 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,435,250,438.67 | 3,472,576,806.28 | 3,497,462,779.88 | 3,665,802,537.87 |
| 资产总计 | 5,947,418,549.87 | 5,791,105,531.13 | 5,962,221,403.29 | 6,248,447,592.06 |
| 流动负债: | | | | |
| 流动负债合计 | 2,039,556,524.03 | 1,940,465,299.39 | 2,156,090,897.3 | 1,812,316,552.13 |
| 非流动负债: | | | | |
| 非流动负债合计 | 513,658,843.13 | 430,240,300.11 | 361,948,647.01 | 761,521,326.37 |
| 负债合计 | 2,553,215,367.16 | 2,370,705,599.5 | 2,518,039,544.31 | 2,573,837,878.5 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,081,606,019.19 | 3,100,445,059.28 | 3,112,857,330.78 | 3,319,385,541.98 |
| 股东权益合计 | 3,394,203,182.71 | 3,420,399,931.63 | 3,444,181,858.98 | 3,674,609,713.56 |
| 负债和股东权益合计 | 5,947,418,549.87 | 5,791,105,531.13 | 5,962,221,403.29 | 6,248,447,592.06 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,572,864,349.54 | 1,224,277,699.86 | 5,074,328,015.47 | 3,718,770,391.37 |
| 经营活动现金流出小计 | 2,335,374,636.15 | 1,178,383,409.51 | 4,469,183,446.89 | 3,181,541,417.71 |
| 经营活动产生的现金流量净额 | 237,489,713.39 | 45,894,290.35 | 605,144,568.58 | 537,228,973.66 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 143,722,934.28 | 105,968,968.08 | 1,277,411,736.06 | 964,855,988.98 |
| 投资活动现金流出小计 | 238,929,163.41 | 92,062,587.66 | 1,571,303,489.72 | 1,238,574,006.53 |
| 投资活动产生的现金流量净额 | -95,206,229.13 | 13,906,380.42 | -293,891,753.66 | -273,718,017.55 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 231,341,934.91 | 81,002,288.92 | 422,830,193.58 | 288,150,542.75 |
| 筹资活动现金流出小计 | 373,133,276.23 | 216,497,009.78 | 798,540,894.65 | 558,186,348.08 |
| 筹资活动产生的现金流量净额 | -141,791,341.32 | -135,494,720.86 | -375,710,701.07 | -270,035,805.33 |
| 汇率变动对现金及现金等价物的影响 | -19,938,479.14 | -8,270,355.53 | -7,126,733.52 | -1,918,721.91 |
| 现金及现金等价物净增加额 | -19,446,336.2 | -83,964,405.62 | -71,584,619.67 | -8,443,571.13 |
| 期末现金及现金等价物余额 | 751,432,502.35 | 686,905,866.93 | 770,870,272.55 | 834,011,321.09 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -19,446,336.2 | - | -71,584,619.67 | - |
最新报告期：2026-08-10| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中金公司 | 张琎,刘雅馨,朱言音 | 0.72 | 0.88 | -- | 2026-08-10 |
| 国金证券 | 何冠洲 | 0.73 | 0.90 | 1.09 | 2026-08-03 |
| 华泰证券 | 代雯,高鹏 | 0.70 | 0.83 | 0.96 | 2026-08-03 |
| 华创证券 | 郑辰,李婵娟 | 0.66 | 0.81 | 0.97 | 2026-05-25 |
| 华源证券 | 刘闯 | 0.66 | 0.84 | 0.98 | 2026-05-21 |